Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karlyne M Reilly

Showing results (11-20 of 52) with videos related to

Pageof 6
Sort By:
Neurogenetics|January 12, 2007
Nf1 expression is dependent on strain background: implications for tumor suppressor haploinsufficiency studiesJessica J Hawes, Robert G Tuskan, Karlyne M Reilly
Journal of Biomolecular Screening|July 31, 2008
Novel dual-reporter preclinical screen for antiastrocytoma agents identifies cytostatic and cytotoxic compoundsJessica J Hawes, John D Nerva, Karlyne M Reilly
BMC Genomics|March 24, 2010
Evidence of perturbations of cell cycle and DNA repair pathways as a consequence of human and murine NF1-haploinsufficiencyAlexander Pemov, Caroline Park, Karlyne M Reilly, et al.
Advances in Cancer Research|April 20, 2010
Genetically engineered mouse models in cancer researchJessica C Walrath, Jessica J Hawes, Terry Van Dyke, et al.
Mammalian Genome : Official Journal of the International Mammalian Genome Society|December 14, 2011
Scram1 is a modifier of spinal cord resistance for astrocytoma on mouse Chr 5Jessica Amlin-Van Schaick, Sungjin Kim, Karl W Broman, et al.
Expert Opinion on Orphan Drugs|August 9, 2020
Developing therapies for rare tumors: opportunities, challenges and progressDiana Bradford, Karlyne M Reilly, Brigitte C Widemann, et al.
Mammalian Genome : Official Journal of the International Mammalian Genome Society|April 7, 2009
Chr 19(A/J) modifies tumor resistance in a sex- and parent-of-origin-specific mannerJessica C Walrath, Kristi Fox, Erika Truffer, et al.
Sarcoma|June 9, 2017
Malignant Peripheral Nerve Sheath Tumors State of the Science: Leveraging Clinical and Biological Insights into Effective TherapiesAeRang Kim, Douglas R Stewart, Karlyne M Reilly, et al.
Journal of Natural Products|December 28, 2012
Isobutylhydroxyamides from the pericarp of Nepalese Zanthoxylum armatum inhibit NF1-defective tumor cell line growthKrishna P Devkota, Jennifer Wilson, Curtis J Henrich, et al.
Phytochemistry Letters|January 21, 2014
Compounds from <i>Simarouba berteroana</i> which inhibit proliferation of <i>NF1</i>-defective cancer cellsKrishna P Devkota, Jennifer A Wilson, Curtis J Henrich, et al.
Pageof 6

Showing results (11-20 of 52) with videos related to

Sort By:
Pageof 6
Neurogenetics|January 12, 2007
Nf1 expression is dependent on strain background: implications for tumor suppressor haploinsufficiency studiesJessica J Hawes, Robert G Tuskan, Karlyne M Reilly
Journal of Biomolecular Screening|July 31, 2008
Novel dual-reporter preclinical screen for antiastrocytoma agents identifies cytostatic and cytotoxic compoundsJessica J Hawes, John D Nerva, Karlyne M Reilly
BMC Genomics|March 24, 2010
Evidence of perturbations of cell cycle and DNA repair pathways as a consequence of human and murine NF1-haploinsufficiencyAlexander Pemov, Caroline Park, Karlyne M Reilly, et al.
Advances in Cancer Research|April 20, 2010
Genetically engineered mouse models in cancer researchJessica C Walrath, Jessica J Hawes, Terry Van Dyke, et al.
Mammalian Genome : Official Journal of the International Mammalian Genome Society|December 14, 2011
Scram1 is a modifier of spinal cord resistance for astrocytoma on mouse Chr 5Jessica Amlin-Van Schaick, Sungjin Kim, Karl W Broman, et al.
Expert Opinion on Orphan Drugs|August 9, 2020
Developing therapies for rare tumors: opportunities, challenges and progressDiana Bradford, Karlyne M Reilly, Brigitte C Widemann, et al.
Mammalian Genome : Official Journal of the International Mammalian Genome Society|April 7, 2009
Chr 19(A/J) modifies tumor resistance in a sex- and parent-of-origin-specific mannerJessica C Walrath, Kristi Fox, Erika Truffer, et al.
Sarcoma|June 9, 2017
Malignant Peripheral Nerve Sheath Tumors State of the Science: Leveraging Clinical and Biological Insights into Effective TherapiesAeRang Kim, Douglas R Stewart, Karlyne M Reilly, et al.
Journal of Natural Products|December 28, 2012
Isobutylhydroxyamides from the pericarp of Nepalese Zanthoxylum armatum inhibit NF1-defective tumor cell line growthKrishna P Devkota, Jennifer Wilson, Curtis J Henrich, et al.
Phytochemistry Letters|January 21, 2014
Compounds from <i>Simarouba berteroana</i> which inhibit proliferation of <i>NF1</i>-defective cancer cellsKrishna P Devkota, Jennifer A Wilson, Curtis J Henrich, et al.
Pageof 6